Viral Vector Patents Status By Others

[VictorMedvil 307]

It seems Uni-valent Retroviral Vector's Patents for usage in gene therapy have finally Expired, Link = (https://patents.google.com/patent/US6544771B1/en)

The Patent over using Uni-Valent Retroviral Vectors with the VSV-G Gene Envelope is also Expired, Link = (https://patents.google.com/patent/US5817491A/en and https://patents.google.com/patent/US5512421A/en)

Multivalent Viral Vector Production Patent is Expired, Link = (https://patents.google.com/patent/US20070218536A1/en and https://patents.google.com/patent/US20100203074A1/en)

Multivalent Bacteriophage Production Patent is active held by Instytut Immunologii i Terapii Doswiadczalnej Until 2022 which is not expired, link = (https://patents.google.com/patent/US7232564B2/en)

Multivalent Viral Vector's Patent is still active held by Janssen Vaccines and Prevention BV along with Aeras Global TB Vaccine Foundation until 2025 which is not expired, Link = (https://patents.google.com/patent/US8202723/de29)

 

Cas9 Gene's Patent is active held by Massachusetts Institute of Technology and Broad Institute Inc until 2033 which is not expired, Link = (https://patents.google.com/patent/US8697359B1/en)

 

 

Now selling Univalent VSV-G Retroviral Vectors for Gene Therapy! Multivalent Bacteriophages in 2022 and Multivalent Viral Vectors in 2025 along with Cas9 Insert Vectors in 2033.

 

Edited January 6 by VictorMedvil